Innogen · News · January 11, 2013

Innogen Weekly News Roundup (17/12/12 - 11/01/13)

Innogen Weekly News Roundup (17/12/12 - 11/01/13)

All the latest news from around the world on the life sciences and emerging technologies.

A weekly roundup of global news on topics, including: agriculture, the bioeconomy, food and energy security, genes and genomics, global health and development, healthcare, innovation systems, pharma, synthetic biology, science and technology.


GM Trials in UK expected to proceed in 2013 (AgProfessional)

Partnerships key to success of global vegetable food value chain (The Financial)

The seeds of another GM row are sown (The Telegraph)

Over 4,500 posts of agricultural scientists vacant: Govt (The Times of India)

Meet the Weeds That Monsanto Can’t Beat (Mother Jones)

Ready to eat: the first GM fist for the dinner table (The Independent)

Bad weather prompting more British farmers to favour GM use (The Guardian)

An environmentalist’s confession – I was wrong about genetically modified crops (Fox News)


Scientific American Partners With InnoCentive To Launch Open Innovation Hub (Crowdsourcing.Org)

Raising awareness of the bioeconomy (NanoWerk)

Food & Energy Security

Policy Shifts Signal Growth Ahead for Advanced Biofuels (Forbes)


Genomics, bears, fruit (Nature Genetics)

Delivering the promise of public health genomics (The Guardian)

It’s All About the Genes and the Brain Machines (MIT Technology Review)

Global Health

Bioscientists develop a biosensor for the early diagnosis of sleeping sickness (Phys.Org)

Vaccine Rule Is Said to Hurt Health Efforts (The New York Times)

Frugal innovation: Devi Shetty’s Narayana Hrudayalaya to conduct heart surgeries at world’s cheapest rates (The Economic Times)

At Year’s End, News of a Global Health Success (The New York Times)

Innovation to fund global health (The Hill)

The Evolving Role of the Private Sector in Global Health (Huffington Post)


Two bowel cancer genes discovered (BBC News)

A clear policy in stem cell therapy will foster innovative healthcare (The Economic Times)

Rare Diseases Getting Attention From Drugmakers – But At High Costs (Huffington Post)

Innovation Systems

The path to innovation and the road to recovery (The Guardian)

Why Innovation Won’t Save Us (Wall Street Journal)

Three Tensions In Medical Innovation to Watch For In 2013 (Forbes)

Four Innovation Trends to Watch in 2013 (Harvard Business Review Blog)

Put innovation at the heart of refugee protection work (The Guardian)


Big Pharma won’t fall off a patent cliff, says S&P (The Telegraph)

R&D Lessons from Pfizer’s New Breast Cancer Drug, PD-332, 991 (Forbes)

Do the Interactions of Pharma With Medical Experts Compromise Health Guidelines? (Forbes)

Science & Technology

What’s More Dangerous: Biology or Synthetic Biology? (Slate)

In the Flesh: The Embedded Dangers of Untested Stem Cell Cosmetics (Scientific American)

Big leaps of 2012: Breakthroughs in science and technology (The Economic Times)

Court allows patenting of stem cell technologies (Times Higher Education)

Science Policy

Brian Cox and Robin Ince: Politicians must not elevate mere opinion over science (New Statesman)

Science and politics need counselling, not a separation (The Guardian)

Science, the public and the history of science (The Guardian)

How Policymakers Are Shaping Ethics Guidelines For Synthetic Biology (New York Genome Center)